The penny stock of Titan Pharmaceuticals Inc. (TTNP) is making a hard push to returning above the one-dollar level after more positive news on Probuphine®. Ever since announcing a $5.5 million direct offering on April 10th, TTNP stock has been unable to return to above $1 per share, falling as low as 0.60 just four weeks ago. Today’s stock purchase ...
14
SEP
SEP
0
Share
